TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35500144

Group type: COMPARATOR
Intervention: Control
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 2-row V/2-row T (2V/2T)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 2-row V/3-row T (2V/3T)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 3-row V/2-row T (3V/2T)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 3-row V/3-row T (3V/3T)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: FEESAs (all groups)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 3-row V/3-row T vs 2-row V/2-row T
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Initial leakage location
Number of subjects: 72
Study: 34018147

Group type: EXPERIMENTAL
Intervention: Combined lipid-lowering therapy (10 mg/day atorvastatin and 10 mg/day ezetimibe)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intensive statin regimen (40 mg/day atorvastatin)
Number of subjects: 200
Study: 36170636

Group type: EXPERIMENTAL
Intervention: Standardized criteria for inpatient palliative care (PC) consultation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triggered inpatient PC consult
Number of subjects: 0
Study: 34515341

Group type: EXPERIMENTAL
Intervention: Reflexology (DR-1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Meditative practices (DR-2)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Reflexology (higher dose after nonresponse)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Meditative practices (higher dose after nonresponse)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 32220916

Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg/day (LIRA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: canagliflozin 100 mg/day (CANA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg plus canagliflozin 100 mg (CANA/LIRA)
Number of subjects: 45
Study: 35213554

Group type: EXPERIMENTAL
Intervention: MDMA-assisted therapy (MDMA-AT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 90
Study: 33642523

Group type: EXPERIMENTAL
Intervention: SO‐1105 (Miconazole Mucoadhesive Tablets)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Miconazole Gel
Number of subjects: 120
Study: 32677897

Group type: EXPERIMENTAL
Intervention: 16-week multimodal exercise program (MEP)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Conventional treatment (Control group, n=118)
Number of subjects: 319
Study: 34100241

Group type: EXPERIMENTAL
Intervention: Geriatric co-management combined with interdisciplinary transitional care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 240
Study: 33731291

Group type: EXPERIMENTAL
Intervention: Subcutaneous volar nerve block (one-injection)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Traditional dorsal digital nerve block (two-injection)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Traditional dorsal digital nerve block
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Subcutaneous volar nerve block
Number of subjects: 409
Study: 33383954

Group type: EXPERIMENTAL
Intervention: Enteral formula plus one sachet/day of synbiotic for four months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Enteral formula (control group) for four months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Synbiotic administration
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methanobrevibacter growth
Number of subjects: 20
Study: 36349596

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (2 mg) and intranasal oxytocin (24 IU)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Transdermal placebo and intranasal oxytocin
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol and intranasal placebo
Number of subjects: 226

Group type: COMPARATOR
Intervention: Transdermal placebo and intranasal placebo
Number of subjects: 226
Study: 34901264

Group type: EXPERIMENTAL
Intervention: IV hydrocortisone administration prior to hemodialysis for 3 consecutive sessions
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (5 ml saline) administered during 3 intervention-free sessions
Number of subjects: 14
Study: 35397973

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) glasses
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Stress Balls (SB)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 34473906

Group type: EXPERIMENTAL
Intervention: RSV immunoprophylaxis with palivizumab
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 32108732

Group type: EXPERIMENTAL
Intervention: Interferential current (IC) - eight electrotherapy sessions twice a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical estriol (E) - vaginal cream, daily application, 0.5 mg/d
Number of subjects: 40
Study: 35062340

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone in addition to oral prednisolone therapy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 33780106

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg plus Tamsulosin 0.4 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg plus capsule lactobacillus (placebo)
Number of subjects: 80
Study: 36209193

Group type: EXPERIMENTAL
Intervention: Cooperation condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Solo condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Parallel condition
Number of subjects: 40
Study: 32902808

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325

Group type: COMPARATOR
Intervention: Control (no tranexamic acid)
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: Neurological deterioration
Number of subjects: 2325
Study: 32225032

Group type: EXPERIMENTAL
Intervention: Promotion of red peppers by a popular social influencer on Instagram (n = 44)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Promotion of energy-dense snacks by a popular social influencer on Instagram (n = 44)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control condition (n = 44)
Number of subjects: 132
Study: 36350651

Group type: EXPERIMENTAL
Intervention: mHealth+I group (mHealth app + nurse case management)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: mHealth group (mHealth app only)
Number of subjects: 221

Group type: COMPARATOR
Intervention: mHealth+I group
Number of subjects: 221
Study: 32916329

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with dental scaling (DS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dental scaling (DS) alone
Number of subjects: 30
Study: 35820757

Group type: EXPERIMENTAL
Intervention: Zhan Zhuang Qigong exercises (5 times a week, 30 min each, for 8 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional medicine
Number of subjects: 72
Study: 33291058

Group type: EXPERIMENTAL
Intervention: Treatment for co-occurring traumatic stress and substance use (details on dosage and duration not available)
Number of subjects: 135
Study: 32522498

Group type: EXPERIMENTAL
Intervention: Domagrozumab (5, 20, and 40 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 120
Study: 35513842

Group type: EXPERIMENTAL
Intervention: $333 monthly cash gift
Number of subjects: 1000

Group type: COMPARATOR
Intervention: $20 monthly cash gift (Control)
Number of subjects: 1000
Study: 33861547

Group type: EXPERIMENTAL
Intervention: Sepsis‐3 criteria
Number of subjects: 5215

Group type: EXPERIMENTAL
Intervention: Angus infection criteria
Number of subjects: 5215

Group type: EXPERIMENTAL
Intervention: Rhee criteria
Number of subjects: 5215

Group type: EXPERIMENTAL
Intervention: Angus criteria
Number of subjects: 5215
Study: 35779242

Group type: EXPERIMENTAL
Intervention: Letrozole 5 mg/day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no letrozole)
Number of subjects: 25
Study: 33822396

Group type: EXPERIMENTAL
Intervention: Intensive BP lowering strategy (SBP <120 mmHg) with ACEi/ARBs plus thiazides
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard BP lowering strategy
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Intensive treatment (SBP <120 mmHg)
Number of subjects: 9361
Study: 32074143

Group type: EXPERIMENTAL
Intervention: Carica papaya leaf extract (CPLE)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 35739000

Group type: EXPERIMENTAL
Intervention: Preoperative EA (B)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Combination of preoperative and intraoperative EA (D)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Intraoperative EA (C)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional group (A)
Number of subjects: 144
Study: 33098114

Group type: EXPERIMENTAL
Intervention: Group prenatal care (PNC)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Individual prenatal care (PNC)
Number of subjects: 218
Study: 34719443

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Terlipressin (TP)
Number of subjects: 30
Study: 34490739

Group type: EXPERIMENTAL
Intervention: Total BCAA level increase
Number of subjects: 0

Group type: COMPARATOR
Intervention: BMI variants increase
Number of subjects: 0
Study: 32706159

Group type: EXPERIMENTAL
Intervention: 10 g okra powder blended in 150 g conventional yogurt
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional yogurt alone
Number of subjects: 60
Study: 35876385

Group type: EXPERIMENTAL
Intervention: FLOT
Number of subjects: 222

Group type: COMPARATOR
Intervention: CROSS
Number of subjects: 222
Study: 33305542

Group type: EXPERIMENTAL
Intervention: Guanfacine extended-release (GXR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 35491383

Group type: EXPERIMENTAL
Intervention: Three-dimensional (3D) visualisation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional learning approaches
Number of subjects: 0
Study: 34710663

Group type: EXPERIMENTAL
Intervention: Anodal vmPFC and dlPFC stimulation with extracranial cathodal electrode
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anodal dlPFC/cathodal vmPFC stimulation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the dlPFC with extracephalic return electrode
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 34
Study: 32269237

Group type: EXPERIMENTAL
Intervention: HOPE-L (Hypothermic Oxygenated Perfusion for Liver)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SCS-L (Static Cold Storage for Liver)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SCS-L
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HOPE-L
Number of subjects: 40

Group type: COMPARATOR
Intervention: SCS-K (Static Cold Storage for Kidney)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HOPE-K (Hypothermic Oxygenated Perfusion for Kidney)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SCS-K
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HOPE-K
Number of subjects: 40
Study: 35738424

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (65%-75% HRmax)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (75%-85% HRmax)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Quiet control group
Number of subjects: 93
Study: 33265082

Group type: EXPERIMENTAL
Intervention: Total Muscle Taping (TMT) group - kinesiology tape applied to erector spinae, latissimus dorsi, lower trapezius, internal oblique abdominis, and external oblique abdominis.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Erector Spinae Taping (EST) group - kinesiology tape applied only to the erector spinae.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between TMT and EST groups.
Number of subjects: 32
Study: 34140596

Group type: EXPERIMENTAL
Intervention: High energy and protein diet (HEP); ME intake 169.0 ± 1.4 MJ/day; CP intake 2.3 ± 0.02 kg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low energy and protein diet (LEP); ME intake 92.9 ± 1.3 MJ/day; CP intake 1.0 ± 0.01 kg/day
Number of subjects: 30
Study: 36062364

Group type: EXPERIMENTAL
Intervention: One-day multi-media training for teachers
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 311
Study: 34816682

Group type: EXPERIMENTAL
Intervention: Dienogest (Vissane 2 mg tablet)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: OCPs (LD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 33781234

Group type: COMPARATOR
Intervention: Control group (no calcium gluconate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium 5 group (5 mg/kg calcium gluconate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium 10 group (10 mg/kg calcium gluconate)
Number of subjects: 0
Study: 33200989

Group type: EXPERIMENTAL
Intervention: Reinforcement learning task with varying reward size and probability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing volatility in the learning task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of depressive symptoms
Number of subjects: 0
Study: 34365959

Group type: EXPERIMENTAL
Intervention: Prefrontal Cortex Transcranial direct current stimulation (tDCS)
Number of subjects: 225
Study: 32808315

Group type: COMPARATOR
Intervention: First intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical test using specific intervention data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total number of periods and lag
Number of subjects: 0
Study: 35087117

Group type: EXPERIMENTAL
Intervention: Family‐Based Empowerment Model (FECM) / Continuing Care Model (CCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed FECM and CCM rehabilitation techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (D)
Number of subjects: 0
Study: 33402159

Group type: EXPERIMENTAL
Intervention: Metformin (started at 500 mg b.i.d. and escalated to 1000 mg b.i.d. after 2 weeks, maximum 2000 mg daily)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Metformin (with lifestyle intervention)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo (with lifestyle intervention)
Number of subjects: 256
Study: 35617960

Group type: EXPERIMENTAL
Intervention: Informational video used to supplement standard in-person verbal and written consent
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard informed consent process (without video)
Number of subjects: 82
Study: 32183708

Group type: EXPERIMENTAL
Intervention: Preventive, complex psychological intervention commenced early in ICU
Number of subjects: 113
Study: 35718205

Group type: EXPERIMENTAL
Intervention: VLA2001 high dose
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: VLA2001 medium dose
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: VLA2001 low dose
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 153
Study: 34730529

Group type: EXPERIMENTAL
Intervention: Combined administration of intravenous (IV) and local tranexamic acid (TXA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous (IV) tranexamic acid (15mg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Local tranexamic acid (2g)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined administration of IV and local tranexamic acid
Number of subjects: 90
Study: 34857710

Group type: EXPERIMENTAL
Intervention: Three-step approach to improve nonadherence (identification of nonadherent patients, determination of underlying causes, personalized solution)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tailored feedback tool for communication on drug levels
Number of subjects: 3
Study: 33838657

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (2 mg/kg/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Dexamethasone (6 mg/day)
Number of subjects: 86
Study: 37145232

Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg/day, increased by 1 mg/day, max 12 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combination of terlipressin (2 mg/day) and noradrenaline (starting at 0.5 mg/h, increased to 3 mg/h)
Number of subjects: 60
Study: 33569809

Group type: EXPERIMENTAL
Intervention: Personal exposure to PM2.5 during Spring Festival
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Blood pressure measurements during Spring Festival
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Factors affecting PM2.5 exposure
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) association with PM2.5 exposure
Number of subjects: 156
Study: 32966280

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 90
Study: 36068369

Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with etch-and-rinse (ER) strategy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with self-etch (SE) strategy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQ) with etch-and-rinse (ER) strategy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQ) with self-etch (SE) strategy
Number of subjects: 176

Group type: COMPARATOR
Intervention: Self-etch (SE) strategy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with self-etch (SE)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Clearfil Universal Bond Quick (CQ) with self-etch (SE)
Number of subjects: 176
Study: 34843372

Group type: EXPERIMENTAL
Intervention: 100% VAB
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 25% VAB
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Summary VAB
Number of subjects: 17
Study: 36460978

Group type: EXPERIMENTAL
Intervention: CAD/CAM with COG
Number of subjects: 22

Group type: COMPARATOR
Intervention: Model based reconstruction (MB group)
Number of subjects: 22
Study: 34969668

Group type: EXPERIMENTAL
Intervention: AI intervention
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard-of-care interventions
Number of subjects: 23
Study: 35280707

Group type: EXPERIMENTAL
Intervention: Morphine combined with mechanical ventilation
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 136
Study: 33719268

Group type: EXPERIMENTAL
Intervention: Syndecan-1 overexpression group (fumigation after injection of 1 mg/ml lipopolysaccharide, and transfection of 100 μl carrying rat syndecan‐1 gene Ad‐CMV‐GFP‐SDC1, n=10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: COPD group (fumigation after injection of 1 mg/ml lipopolysaccharide, transfection of 100 μl empty virus, n=10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham operation group (normal saline injection after tracheal exposure, n=10)
Number of subjects: 30
Study: 35737855

Group type: EXPERIMENTAL
Intervention: 0.5 mg/day ETV
Number of subjects: 137

Group type: COMPARATOR
Intervention: 0.5 mg/day ETV maleate
Number of subjects: 137
Study: 32520696

Group type: EXPERIMENTAL
Intervention: 8-week nurse-coordinated, multidisciplinary cardiovascular prevention and rehabilitation programme (CVPRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care hospital (control)
Number of subjects: 0
Study: 35986241

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention (counselling with pictogram-enhanced medication instructions and smartphone medication reminders)
Number of subjects: 325
Study: 33713618

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TAVR with evidence of hypoattenuated leaflet thickening (HALT) at 30 days
Number of subjects: 200
Study: 32737072

Group type: EXPERIMENTAL
Intervention: Ozanimod HCl 0.5 mg/d
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ozanimod HCl 1 mg/d
Number of subjects: 24

Group type: COMPARATOR
Intervention: Baseline (day 1)
Number of subjects: 24
Study: 36474225

Group type: EXPERIMENTAL
Intervention: Animation education
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Game education
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 275
Study: 34032717

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Acupressure
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg and Acupressure
Number of subjects: 58
Study: 32268328

Group type: EXPERIMENTAL
Intervention: Brochure-based lifestyle intervention programme
Number of subjects: 173

Group type: COMPARATOR
Intervention: Routine antenatal care
Number of subjects: 173

Group type: COMPARATOR
Intervention: Prenatal lifestyle intervention sessions
Number of subjects: 173

Group type: COMPARATOR
Intervention: Normal BMI mothers (control group)
Number of subjects: 173
Study: 34151533

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Partial meniscectomy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Quadriceps muscle strength
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Hamstrings muscle strength
Number of subjects: 140
Study: 33174296

Group type: EXPERIMENTAL
Intervention: Overlap weighting (OW) method for covariate adjustment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse probability weighting (IPW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of covariance (ANCOVA)
Number of subjects: 0
Study: 35678835

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises applied from the 30th week of gestation to the 6th week postpartum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no pelvic floor muscle exercise training)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises
Number of subjects: 60
Study: 34526429

Group type: EXPERIMENTAL
Intervention: Ranitidine Bismuth Citrate (RBC) pretreatment for 2 weeks before standard triple therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard treatment (esomeprazole, amoxicillin, and clarithromycin for 7 days)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ranitidine Bismuth Citrate (RBC) pretreatment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 99